Global Future Council on Antimicrobial Resistance

Global Future Council on Antimicrobial Resistance

Antimicrobial resistance (AMR) is already a leading cause of death globally, higher than HIV/AIDS or malaria. What novel approaches are needed to accelerate effective action on AMR?

Members
Chief Executive Officer, Dubai Health
Amer Ahmad Sharif
Antimicrobial Resistance Control and One Health Unit Lead, Africa Centres for Disease Control and Prevention (Africa CDC)
Yewande Alimi
Visiting Senior Fellow, LSE Health, London School of Economics and Political Science
Michael Anderson
Chief, External Affairs, CARB-X
Damiano de Felice
South African Research Chair in Antibiotic Resistance and One Health; Professor in Pharmaceutical Sciences, University of KwaZulu-Natal
Sabiha Essack
Director, Global Public Policy, MSD
Gregory Frank
Principal, Antimicrobial Resistance, IQVIA
Rachel Freeman
Professor of Infectious Diseases; Director, Fleming Initiative, Imperial College London
Alison Holmes
Head of Policy, Infectious Disease, Wellcome Trust
Jeremy Knox
Director, Investment Stewardship, Asset Management, Legal & General Group
Maria Larsson Ortino
Senior Manager, Public Affairs, Communications and Stakeholder Relations, Novo Nordisk Foundation
Alexandra Lichtenstein Kaarsen
Policy Fellow, Center for Global Development
Anthony McDonnell​
Country Director, Nigeria, PharmAccess Foundation
Njide Ndili
Coordinator, Antimicrobial Resistance and Infection Prevention and Control Programme, Nigeria Centre for Disease Control (CDC)
Tochi Okwor
Director, International Policy, AMR Action Fund
Deepali Patel
Professor, School of Public Health, Peking University
Ren Minghui
Editor-in-Chief, AMR.Solutions
John Rex
Senior Health Specialist, World Bank Group
Naomi Rupasinghe​
Deputy Director, Gates Foundation
Padmini Srikantiah
Chair, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Jeffrey L. Sturchio

関連 レポート

関連 ビデオ

世界経済フォーラムについて

詳細

エンゲージメント

リンク

言語

プライバシーポリシーと利用規約

サイトマップ

© 2025 世界経済フォーラム